InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.
IVRO stock price ended at $0.13 on 星期五, after rising 0.00%
On the latest trading day Jan 16, 2026, the stock price of IVRO rose by 0.00%, climbing from $0.13 to $0.13. During the session, the stock saw a volatility of 16.67%, with prices oscillating between a daily low of $0.12 and a high of $0.14. Notably, trading volume dropped by 50.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 81.9K shares were traded, equating to a market value of approximately $2.9M.